Introduction Clinical manifestations of multiple myeloma (MM) include anemia, recurrent infections, renal insufficiency, osteolytic bone lesions and hypercalcemia (1). Majority of the patients develop renal failure from the disease, and before widespread dialysis availability, renal failure was the second leading cause of death in MM (1). During th